As of 2025-07-04, the Intrinsic Value of Biomerieux SA (BIM.PA) is 64.29 EUR. This BIM.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 119.00 EUR, the upside of Biomerieux SA is -46.00%.
The range of the Intrinsic Value is 45.71 - 112.55 EUR
Based on its market price of 119.00 EUR and our intrinsic valuation, Biomerieux SA (BIM.PA) is overvalued by 46.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 45.71 - 112.55 | 64.29 | -46.0% |
| DCF (Growth 10y) | 51.01 - 117.36 | 69.64 | -41.5% |
| DCF (EBITDA 5y) | 65.76 - 95.58 | 76.04 | -36.1% |
| DCF (EBITDA 10y) | 69.57 - 105.60 | 82.50 | -30.7% |
| Fair Value | 52.58 - 52.58 | 52.58 | -55.82% |
| P/E | 98.28 - 115.97 | 106.47 | -10.5% |
| EV/EBITDA | 109.95 - 285.81 | 171.63 | 44.2% |
| EPV | 27.16 - 37.55 | 32.35 | -72.8% |
| DDM - Stable | 34.95 - 115.74 | 75.35 | -36.7% |
| DDM - Multi | 44.66 - 113.48 | 63.93 | -46.3% |
| Market Cap (mil) | 14,084.84 |
| Beta | 0.57 |
| Outstanding shares (mil) | 118.36 |
| Enterprise Value (mil) | 14,341.04 |
| Market risk premium | 5.82% |
| Cost of Equity | 8.08% |
| Cost of Debt | 5.00% |
| WACC | 7.93% |